Efficacy and safety of Glucagon-like peptide-1 receptor agonist (GLP-1RA) plus basal insulin versus basal insulin in Type 2 Diabetes Mellitus: A Systematic review and Meta-analysis

Aaron Liew

Efficacy and safety of Glucagon-like peptide-1 receptor agonist (GLP-1RA) plus basal insulin versus basal insulin in Type 2 Diabetes Mellitus: A Systematic review and Meta-analysis

Aaron Liew

Medicine

Research output: Other contribution (Published) › Other contribution

Original language	English (Ireland)
Media of output	Other Item
Volume	186
Publication status	Published - 1 Sep 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{cd86fd8df17c4d85bd21935a92985d3d,

title = "Efficacy and safety of Glucagon-like peptide-1 receptor agonist (GLP-1RA) plus basal insulin versus basal insulin in Type 2 Diabetes Mellitus: A Systematic review and Meta-analysis",

author = "Aaron Liew",

year = "2017",

month = sep,

day = "1",

language = "English (Ireland)",

volume = "186",

type = "Other",

}